1/18/2021 1:11:40 AM
Roche Holding Says AGM To Take Place On March 16, 2021
1/12/2021 1:03:41 AM
Roche To Present Updated OS Data From Phase III IMbrave150 Study Of Tecentriq With Avastin
1/11/2021 1:06:18 AM
Roche: European Commission Approved Xofluza For Uncomplicated Influenza
1/5/2021 1:04:16 AM
Genentech Says Tiragolumab Granted FDA Breakthrough Therapy
Designation In Combination With Tecentriq
12/23/2020 1:02:39 AM
Roche Says EU Approves Phesgo For Treatment Of Early And Metastatic HER2-positive Breast Cancer
12/21/2020 1:05:33 AM
Genentech Says Positive Topline Results From Phase III Studies, YOSEMITE And RHINE, Evaluating Faricimab For DME
12/15/2020 1:09:52 AM
Roche Launches Cobas PIK3CA Mutation Test For Patients With Advanced Or Metastatic Breast Cancer
12/14/2020 6:09:35 AM
Relay Therapeutics Announces Worldwide License And Collaboration Deal With Genentech For RLY-1971
12/11/2020 1:05:12 AM
Roche Launches Laboratory SARS-CoV-2 Antigen Test To Support High-volume Testing Of COVID-19